Johnson & Johnson schlägt zu – 100 Prozent Aufschlag
Johnson & Johnson (J&J) wird 2,0 Milliarden Dollar in bar zahlen, um Ambrx Biopharma zu erwerben und damit einen Entwickler…
143,360€
0,10%
Echtzeit-Aktienkurs Johnson & Johnson
Bid:
Ask:
Nachrichten zur Johnson & Johnson Aktie
PRTG: Bridging I-O: Working in Harmony with Checkpoints
By John Vandermosten, CFA
NASDAQ:PRTG
READ THE FULL PRTG RESEARCH REPORT
We are initiating coverage of Portage Biotech Inc. (NASDAQ:PRTG) with a target…
Johnson & Johnson: 2,0 Milliarden Dollar für Ambrx Biopharma - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär":
Michael Diertl vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…
Johnson & Johnson: Übernahme lässt diese Aktie explodieren
Johnson & Johnson plant die Übernahme eines Biotechnologieunternehmens für zwei Milliarden US-Dollar, um sein Onkologie-Portfolio zu erweitern.…
Johnson & Johnson to acquire Ambrx for $2B
Johnson & Johnson (NYSE:JNJ) has announced its definitive agreement to acquire Ambrx Biopharma, a clinical-stage biopharmaceutical company, in an all-cash...…
Johnson & Johnson to acquire Ambrx in $2 billion deal
…
Johnson & Johnson to Acquire Ambrx for $2 billion By Investing.com
Johnson & Johnson to Acquire Ambrx for $2 billion…
Ambrx Announces Sale to Johnson & Johnson
SAN DIEGO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ambrx Biopharma, Inc., or Ambrx (NASDAQ: AMAM), today announced that…
Johnson & Johnson: Kursziel gekürzt
London (www.aktiencheck.de) - Rating-Update:
Die Analysten von Barclays stufen die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046, WKN: 853260, Ticker-Symbol:…
Johnson & Johnson: Overblown Stelara Concerns Distract From Value
…
Johnson & Johnsons Bullish Outlook: Surprising Strength You Shouldnt Overlook
…
Johnson Outdoors Inc.: Corrective Actions Required, Downgrade To Sell
…
Johnson & Johnson: A Defensive Dividend King Set To Outperform The S&P 500
…
Johnson & Johnson: One Of The Worlds Safest Stocks Could Return +10% Per Year
…
Johnson & Johnson: Rock Solid 3% Yield With Over 10% Annual Return Potential (Rating Upgrade)
…
Global Pharmaceuticals Market Analysis and Forecast to 2027, with Company Profiles of Key Market Players Bayer, Novartis ,Pfizer and Johnson & Johnson
Dublin, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027"…
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what…
Reckitts Mead Johnson Nutrition recalls baby formula powder from US -FDA By Reuters
Reckitts Mead Johnson Nutrition recalls baby formula powder from US -FDA…
Judge certifies Johnson & Johnson shareholder class action over talc disclosures By Reuters
© Reuters. FILE PHOTO: Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York October 15,…
Johnson & Johnson holders allowed to sue as a class over talc disclosures, judge rules
…
Judge certifies Johnson & Johnson shareholder class action over talc disclosures By Reuters
Judge certifies Johnson & Johnson shareholder class action over talc disclosures…
LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets
SHANGHAI, China and PRINCETON, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated…
Nanobiotix Partner LianBio Assigns Its Development and Commercialization Rights for NBTXR3 in China and Other Asian Markets
PARIS and CAMBRIDGE, Mass., Dec. 26, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX –…
Global Engineered Stone Market Size To Worth USD 40.38 Billion By 2032 | CAGR Of 5.4%
The Global Engineered Stone Market Size was valued at USD 23.7 Billion in 2022 and the Worldwide Engineered Stone Market…
Johnson Outdoors: Lower Price Isnt Attractive Enough Yet
…
Johnson & Johnson: Ottava Surgical Robot Is A Growth Tailwind
…
Reasons Why You Should Avoid Betting on Johnson Controls (JCI)
Weakness in the Global Products segment, increasing costs and unfavorable foreign-currency movement are weighing on Johnson Controls (JCI) operations.…
Analyst Report: Johnson Controls Intl pl
…
Johnson Outdoors Inc. Annual Shareholders Meeting
RACINE, Wis., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of…
Johnson & Johnson EPS growth will be muted over the next few years - Wells Fargo By Investing.com
Johnson & Johnson EPS growth will be muted over the next few years - Wells Fargo…
Johnson Controls Using Green-Dominance To Pivot To High-Value Services
…
Johnson & Johnson: Neues Kursziel
New York (www.aktiencheck.de) - Rating-Update:
Terence Flynn, Analyst von Morgan Stanley, bewertet die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046,…
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in…
Disposable Surgical Sheet Market Latest Report | Expansive Coverage on the Profit Sources
Companies covered in this report are Cardinal Health, Paul Hartmann AG, Standard Textile Co., Medline Industries Inc., Molnlycke Health Care…
Johnson & Johnson: Herabstufung! Gewinnwachstum gedämpft - Aktienanalyse
San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo Advisors:
Larry Biegelsen, Analyst von Wells Fargo Advisors, stuft die Aktie…
Johnson Controls sees continued order momentum but profit dips
Johnson Controls International PLC said it continued to see strong order momentum as it reported a modest increase in fourth…
Per-Encounter Medical Market is Booming and Expected to Reach USD 377.93 Billion by 2031 | Latest InsightAce Study
Companies covered in this study are Abbott, Cardinal Health, Johnson & Johnson, Medtronic, 3M, Steris, Catalent Inc., Smiths Medical Inc.,…
Johnson Controls (JCI) Lags Q4 Earnings and Revenue Estimates
Johnson Controls (JCI) delivered earnings and revenue surprises of -3.67% and 2.62%, respectively, for the quarter ended September 2023. Do…
Johnson Controls (JCI) Q4 Earnings Miss, Revenues Rise Y/Y
Johnson Controls (JCI) fiscal fourth-quarter results benefit from strength in the HVAC & Controls and Fire & Security businesses.…
Johnson Outdoors (JOUT) Q4 Earnings and Sales Miss Estimates
Moderating pandemic-driven demand and elevated retail inventory levels hurt Johnson Outdoors (JOUT) Q4 performance.…
Johnson Outdoors Inc. (JOUT) Q4 2023 Earnings Call Transcript
…
WDH/Nachahmerkonkurrenz: Johnson & Johnson rechnet mit weniger Wachstum
(Tippfehler in der Überschrift behoben)
NEW BRUNSWICK (dpa-AFX) - Wegen zunehmender Generika-Konkurrenz für…
Nahmahmerkonkurrenz: Johnson & Johnson rechnet mit weniger Wachstum
NEW BRUNSWICK (dpa-AFX) - Wegen zunehmender Generika-Konkurrenz für einen seiner wichtigsten Kassenschlager rechnet der Arzneimittelhersteller Johnson…
Johnson & Johnson übernimmt Medizintechnikspezialist Laminar - Ziele angepasst
NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson übernimmt den bisher privat…
Johnson & Johnson wird erneut zuversichtlicher
NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson hebt nach einem unerwartet…
Nach Trennung von Konsumgütersparte: Johnson & Johnson fasst Jahresziele neu
NEW BRUNSWICK (dpa-AFX) - Nach Trennung seines Konsumgütergeschäftes hat der Pharma- und Medizintechnikkonzern Johnson & Johnson…
Johnson & Johnson wird erneut optimistischer - Medizintechnik floriert
NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Konsumgüterkonzern Johnson & Johnson hebt nach einem unerwartet…
Johnson & Johnson hebt Jahresziele an - Quartalsverlust nach Milliardenvergleich
NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Konsumgüterkonzern Johnson & Johnson ist besser als erwartet…
Johnson & Johnson will 'Baby Powder'-Klagen mit Milliarden-Vergleich beilegen
NEW BRUNSWICK (dpa-AFX) - Der US-Pharmakonzern Johnson & Johnson (J&J) will einen großen Rechtsstreit um…
Gericht verpasst Johnson & Johnson Dämpfer um krebsverdächtiges Babypuder
NEW BRUNSWICK (dpa-AFX) - Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson hat im Zusammenhang mit…